Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis.

Details

Language :

English

ISSN :

23327812

Volume :

10

Issue :

1

Database :

Complementary Index

Journal :

Neurology® Neuroimmunology & Neuroinflammation

Publication Type :

Academic Journal

Accession number :

161139745

Full Text :

https://doi.org/10.1212/NXI.0000000000200052